Cardio-TriTest vs OPTIS Mobile Next Imaging

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cardio-TriTest

by Cardio-Phoenix

OPTIS Mobile Next Imaging

by Abbott Medical

AI Verdict

Both tools apply AI within cardiology, but they serve distinct purposes. Cardio-TriTest is designed for non-invasive cardiovascular disease detection in primary care settings, utilizing external bio-signals. In contrast, OPTIS Mobile Next Imaging provides invasive guidance for percutaneous coronary intervention (PCI) procedures within catheterization laboratories, using intravascular imaging and physiology measurements.

Choose Cardio-TriTest if…

Choose Cardio-TriTest if your primary care clinic or internal medicine practice requires a comprehensive, non-invasive diagnostic tool for earlier and broader cardiovascular disease detection. It is ideal for synchronizing and visually correlating multiple heart bio-signals (ECG, PCG, MCG) to provide a holistic initial assessment of cardiac health in a clinical setting.

View Cardio-TriTest →

Choose OPTIS Mobile Next Imaging if…

Choose OPTIS Mobile Next Imaging if your catheterization lab needs an advanced, AI-powered system to guide percutaneous coronary intervention (PCI) procedures with high-resolution intravascular imaging and real-time coronary physiology measurements. This transportable device is best suited for interventional cardiologists seeking detailed insights from OCT and RFR/FFR to optimize stent placement and treatment strategies within the cath lab environment.

View OPTIS Mobile Next Imaging →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cardio-TriTest	OPTIS Mobile Next Imaging
Deployment	On-premise (device)	On-premise (mobile cart system integrated into catheterization laboratories)
FDA Status	Unknown	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardio-TriTest

Cardio-TriTest (Tool A) is designed for primary care, offering a non-invasive test procedure that integrates seamlessly into existing ECG workflows and can be operated by nurses or HCAs. Its visual correlation of synchronized bio-signals simplifies interpretation for general practitioners. In contrast, OPTIS Mobile Next Imaging (Tool B) is for complex, invasive cath lab procedures, despite its optimized workflow features like a wireless controller and rapid processing.

Clinical Value

OPTIS Mobile Next Imaging

OPTIS Mobile Next Imaging (Tool B) provides high-resolution OCT and coronary physiology measurements to directly guide PCI procedures, with clinical data showing changes in treatment decisions in 86% of lesions and improved outcomes. Its AI-powered Ultreon Software offers automated evaluation and practical advice during interventions. Cardio-TriTest (Tool A) offers earlier and more comprehensive cardiovascular disease detection in primary care, identifying 'Echo Diseases' traditionally missed by standard ECGs, but Tool B's direct impact on complex interventional outcomes gives it a slight edge.

Pricing & Value

Tie

Both Cardio-TriTest (Tool A) and OPTIS Mobile Next Imaging (Tool B) require direct contact with the vendor for pricing information. Without transparent pricing or detailed cost-effectiveness studies for either product, it is not possible to definitively assess which offers superior pricing or overall value.

Enterprise Readiness

OPTIS Mobile Next Imaging

OPTIS Mobile Next Imaging (Tool B) demonstrates strong enterprise readiness with explicit features like seamless and secure integration with cath lab IT systems and DICOM, including Modality Worklist Query and export to storage servers. It is also a transportable system designed for use across multiple cath labs. While Cardio-TriTest (Tool A) is HIPAA compliant and mentions EMR import paths, it lacks the detailed integration and scalability features for a complex hospital environment that Tool B offers.

Innovation

OPTIS Mobile Next Imaging

OPTIS Mobile Next Imaging (Tool B) showcases advanced innovation by integrating high-resolution OCT, coronary physiology measurements, and AI-powered Ultreon Software with simultaneous angio co-registration on a mobile platform for real-time PCI guidance. This multi-modal data fusion for immediate interventional action represents a distinct advancement in procedural support. Cardio-TriTest (Tool A) is also innovative with its 3-in-1 synchronized bio-signal analysis and AI for 'echo-equivalent' findings in primary care, but Tool B's application in a high-stakes interventional setting is arguably more cutting-edge.

Support & Docs

OPTIS Mobile Next Imaging

Abbott Medical, the company behind OPTIS Mobile Next Imaging (Tool B), is a large, established medical device manufacturer that provides extensive documentation, including operation and maintenance manuals, user guides, and instructions for use, along with dedicated technical service. Cardio-Phoenix Inc., for Cardio-TriTest (Tool A), has limited publicly available information regarding its customer support infrastructure or detailed documentation beyond a general contact email.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cardio-TriTest	OPTIS Mobile Next Imaging
Product Name	Cardio-TriTest	OPTIS Mobile Next Imaging
Company	Cardio-Phoenix Inc.	Abbott Medical
Primary Diagnostic/Imaging Focus	Earlier and more comprehensive cardiovascular disease detection in primary care.	Guide PCI procedures with enhanced efficiency and informed decision-making in cath labs.
Core Technologies/Modalities	3-in-1 diagnostic device (ECG, PCG, MCG); 12-Lead Electrocardiograph (ECG); 4 Lead Phonocardiograph (PCG); 4 Lead Mechanocardiograph (MCG)	Optical Coherence Tomography (OCT) intravascular imaging; Coronary physiology measurements (RFR/FFR)
Target Specialties	Cardiology, Family Medicine, Internal Medicine	Cardiology
AI Application	AI-powered analysis for heart disease detection	High-powered processors supporting AI technology (Ultreonu2122 Software) for faster information display and workflow efficiency
Mobility/Portability	Not specified	Transportable system designed for use in multiple cath labs via easy pre-installed connections

Videos

Demos, reviews, and walkthroughs featuring Cardio-TriTest and OPTIS Mobile Next Imaging.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for cardiovascular care, and what specific patient populations are they best suited for?

Cardio-TriTest is designed for earlier, non-invasive cardiovascular disease detection in primary care, suitable for a broad patient population in general practice, family medicine, and internal medicine. OPTIS Mobile Next Imaging is tailored for interventional cardiology in cath labs, providing real-time guidance during PCI procedures for patients undergoing revascularization.

What level of integration can be expected with existing Electronic Health Record (EHR) systems and how are audit trails managed for diagnostic and procedural data?

OPTIS Mobile Next Imaging offers seamless and secure integration with cath lab IT systems and DICOM, facilitating comprehensive data transfer and robust audit trails for interventional procedures. For Cardio-TriTest, while it's a device-based system for diagnostics, specific details on its EHR integration capabilities and audit trail features would require further inquiry.

What are the reported accuracy and sensitivity metrics for the AI-powered analysis in detecting cardiovascular conditions or guiding interventions?

Cardio-TriTest uses AI for earlier and more comprehensive cardiovascular disease detection by correlating multiple bio-signals, with its AI-derived ECG showing high correlation to standard 12-lead ECG. OPTIS Mobile Next Imaging leverages AI (Ultreonu2122 Software) for faster information display and workflow efficiency during PCI, with clinical data demonstrating its ability to change physician decisions in a high percentage of cases and improve outcomes.

What is the typical learning curve for physicians and support staff, and how quickly can a practice or cath lab expect to realize the clinical and operational benefits?

Cardio-TriTest, as a non-invasive diagnostic device, likely has a relatively short learning curve for primary care staff, enabling quick integration and time-to-value for early detection. OPTIS Mobile Next Imaging, with its wireless Tableside Controller and rapid image processing, aims for efficient adoption in cath labs, allowing for faster informed decision-making during PCI.

How are multi-site rollouts supported, and what kind of ongoing technical and clinical support is provided to ensure optimal performance across different locations?

OPTIS Mobile Next Imaging is designed as a transportable system with easy pre-installed connections, making it suitable for use in multiple cath labs within a health system. For Cardio-TriTest, multi-site deployment would focus on device management and consistent training across various primary care clinics, with support quality being a key consideration.

Which specific clinical scenarios or patient presentations would most benefit from each tool's unique capabilities?

Cardio-TriTest is ideal for primary care physicians and general cardiologists for routine screenings or symptomatic patients requiring early, non-invasive detection of a broad range of cardiovascular diseases. OPTIS Mobile Next Imaging is specifically designed for interventional cardiologists in the cath lab, providing critical real-time intravascular imaging and physiological data to optimize percutaneous coronary intervention (PCI) procedures.